IL-12/Th1 and IL-23/Th17 Biliary Microenvironment in Primary Biliary Cirrhosis: Implications for Therapy
Authors:
- Chen-Yen YangCYChen-Yen Yang
- Xiong MaXMXiong Ma
- Koichi TsuneyamaKTKoichi Tsuneyama
- Shanshan HuangSHShanshan Huang
- Toru TakahashiTTToru Takahashi
- Naga P. ChalasaniNCNaga P. Chalasani
- Christopher L. BowlusCBChristopher L. Bowlus
- Guo-Xiang YangGYGuo-Xiang Yang
- Patrick S.C. LeungPLPatrick S.C. Leung
- Aftab A. AnsariAAAftab A. Ansari
- Linda WuLWLinda Wu
- Ross L. CoppelRCRoss L. Coppel
Open Access
- 21 December 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 59 (5) , 1944-1953
Abstract
The interleukin (IL)-12/IL-23-mediated Th1/Th17 signaling pathway has been associated with the etiopathogenesis of primary biliary cirrhosis (PBC). To address the cytokine microenvironment specifically in the liver, we examined the localized expression of cytokine subunits and their corresponding receptors using previously optimized immunohistochemistry with an extensive panel of antibodies directed at IL-12p70, IL-12p35, interferon-gamma (IFN-γ), IL-12RB2, IL-23p40, IL-23p19, IL-17, and IL-23R using liver from PBC (n = 51) and non-PBC (n = 80) control liver disease patients. Multiple portal tracts in each patient were blindly evaluated and individually scored. We report herein that although IL-12/Th1 and IL-23/Th17 staining was detected in all of the liver sections, they were primarily localized around the damaged interlobular bile ducts in PBC. Most important, Th17 skewing was prominent in advanced PBC patients with intensive secretion of IL-23p19 by inflamed hepatocytes around IL-23R, IL-12RB2, and IFN-γ expressing degenerated cholangiocytes. Our novel finding on the direct association of Th17 skewing and disease severity illustrates the significance of the IL-23/Th17 pathway in the perpetuation of IL-12/Th1-mediated immunopathology in PBC. Furthermore, localized IL-23p19 production by hepatocytes may enhance profibrotic Th17 signaling and proinflammatory IFN-γ production that contribute to PBC pathology. Conclusion : Our data emphasize the pathogenic relevance of IL-12/Th1 and IL-23/Th17 in the evolution of PBC. Of significance, however, the shift from a Th1 to a Th17 imbalance at advanced stages of the disease suggests the necessity to consider modulation of the IL-23/Th17 pathway as a potential target for therapeutic intervention. (Hepatology 2014;59:1944–1953)Keywords
Funding Information
- National Institutes of Health (DK39588)
This publication has 32 references indexed in Scilit:
- Primary Biliary Cirrhosis Associated withHLA, IL12A,andIL12RB2VariantsNew England Journal of Medicine, 2009
- KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung CancerClinical Cancer Research, 2009
- Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell populationClinical and Experimental Immunology, 2009
- Hepatic IL-17 responses in human and murine primary biliary cirrhosisJournal of Autoimmunity, 2009
- Role of Th1 and Th17 cells in organ-specific autoimmunityJournal of Autoimmunity, 2008
- Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease†Hepatology, 2008
- Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axisJournal of Clinical Investigation, 2008
- Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector categoryJournal of Experimental Medicine, 2008
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- New IL-12-family members: IL-23 and IL-27, cytokines with divergent functionsNature Reviews Immunology, 2005